iPhone | iPad
Android
Huawei
At just over 0.2 per cent, the country’s death rate also remains among the lowest globally
KT APPDOWNLOAD
Covid-19: India's Covovax vaccine gets WHO emergency approval
'This listing aims to increase access particularly in lower-income countries'
AFP file
The World Health Organization (WHO) on Friday announced it has granted emergency approval to the India-manufactured coronavirus vaccine Covovax.
The jab, produced by Serum Institute of India under licence from the US-based Novavax, will now be distributed as part of global vaccine-sharing system Covax, "giving a much-needed boost to ongoing efforts to vaccinate more people in lower-income countries", WHO said in a statement.
"Even with new variants emerging, vaccines remain one of the most effective tools to protect people against serious illness and death from SARS-COV-2," said Mariangela Simao, the WHO's access to vaccines chief.
"This listing aims to increase access particularly in lower-income countries, 41 of which have still not been able to vaccinate 10 percent of their populations, while 98 countries have not reached 40 percent," she said.
Covovax requires two doses and is stable at 2 to 8 degrees Celsius refrigerated temperatures.
More news from coronavirus
Over 179 million PCR tests have been conducted in the country so far
The announcement coincides with a drop in the number of registered coronavirus cases
Over 178.6 million PCR tests have been conducted in the country so far
A total of at least eight cities and towns say their residents must not go beyond where they live
City health officials warn infections could hit 8,000 in the coming weeks
Foreigners who want to leave must test negative in five PCR tests over seven days
Over 178.6 million PCR tests have been conducted in the country so far